Wolverine Stack Drug Interactions in Dogs: What to Know

The Wolverine Stack is the informal name owners use for BPC-157 and TB-500 taken together, and on the interaction question the honest answer is this: there is no published drug-interaction database for these peptides in dogs, so nobody can hand you a definitive list. What can be said is mechanistic. Peptides are short chains of amino acids broken down by peptidase enzymes into their component amino acids, rather than routed through the liver's cytochrome P450 enzyme system where the majority of classic drug-drug interactions arise. That is the pharmacological reason owners so often run the stack alongside a veterinarian's post-operative plan rather than in place of it. It is not, however, a reason to skip the conversation — your vet needs the full list of everything your dog is taking.

Where the name comes from, and what is actually in the stack

The label started in human biohacking circles, where BPC-157 and TB-500 were paired for soft-tissue recovery and the nickname stuck. It travelled into the dog world largely through owners managing cruciate injuries, tendon strains, post-surgical recovery and the slow mobility decline of older dogs.

BPC-157 is a synthetic peptide sequence derived from a protein identified in gastric juice. Published laboratory work describes it in terms of angiogenesis — the formation of new blood vessels — and fibroblast migration, the movement of the cells that lay down collagen in a healing tendon or ligament.

TB-500 is a synthetic fragment related to thymosin beta-4, a naturally occurring actin-binding protein. The literature associates thymosin beta-4 with cell migration, new vessel formation and modulation of the inflammatory phase of injury.

Much of that published work sits in laboratory and animal injury models rather than in large controlled canine trials, and neither compound is an FDA-approved veterinary drug. What makes the pairing compelling to owners is that the mechanisms described are precisely the processes an injured tendon depends on: blood supply, cell migration, and orderly collagen remodelling that continues long after a dog looks sound on a walk. Research suggests these are complementary rather than duplicate mechanisms, which is why the two are usually discussed together instead of separately.

Why peptides and prescription drugs sit on different clearance pathways

Understanding interactions means understanding how a drug leaves the body. Most small-molecule medications a dog receives after orthopaedic surgery — carprofen, meloxicam, gabapentin — are metabolised largely in the liver, many of them by cytochrome P450 enzymes, and many bind to plasma proteins while they circulate. Two drugs competing for the same enzyme or the same protein binding site can push each other's blood levels up or down. That competition is the engine behind most of the interaction warnings on a pharmacy label.

Peptides are handled differently. As a general principle of peptide pharmacology, they are degraded proteolytically — chopped up by enzymes into amino acids the body reuses — rather than processed through those hepatic enzyme routes. There is no shared enzyme to compete for, which is why the classic interaction mechanism is a different conversation for a peptide than for two overlapping anti-inflammatories.

That said, absence of a shared metabolic pathway is not the same as absence of any interaction. Two substances can act on the same biological process without ever meeting in the liver. Anything that influences blood vessel growth, clotting, immune signalling or inflammation sits in territory where a veterinarian may reasonably want to think about overlap, particularly around an anaesthetic event or in a dog with a complex medical history. That is a clinical judgement, not a label lookup, and it belongs to your vet.

The medications a recovering dog is usually already taking

Most dogs whose owners are researching this stack are already on something. Here is what those medications are doing and what is worth putting in front of your veterinarian before you add anything.

Medication or therapy	What it is doing	What to raise with your vet
NSAIDs (carprofen, meloxicam, deracoxib)	Controls inflammation and post-operative pain; the backbone of most recovery plans	Confirm the plan continues unchanged; ask what GI and bloodwork monitoring is expected
Gabapentin, amantadine	Targets nerve-related and chronic pain, often alongside an NSAID	Ask whether added sedation or wobbliness should change crate-rest handling
Anti-NGF monoclonal antibody injections (Librela)	A prescribed monthly injection for osteoarthritis pain	Note the injection schedule so your vet can interpret any change in comfort
Corticosteroids (prednisone)	Suppresses inflammation and immune activity; never combined with NSAIDs	Steroid protocols warrant a specific discussion before adding any supplement
Post-operative antibiotics	Prevents or treats surgical site infection	Complete the full course exactly as prescribed
Polysulfated glycosaminoglycan injections	Prescription joint therapy given on a set schedule	Mention it so your vet has the whole joint-support picture
Trazodone or other sedatives	Keeps a dog calm enough to honour restricted activity	Report any change in alertness or appetite
Anticoagulant or antiplatelet medication	Manages clotting risk in specific cardiac or clotting disorders	Flag this early; clotting and vessel biology deserve individual assessment

Nothing on that list should be reduced, paused or stopped to make room for a supplement — the prescription plan is the foundation, and a peptide stack is something owners layer on top of it, with their veterinarian's knowledge.

Where extra caution genuinely belongs

There are situations where the sensible answer is a specific conversation rather than a general one.

Dogs with cancer or a history of neoplasia sit at the top of that list. Mechanisms described in the peptide literature — angiogenesis and cell migration — overlap conceptually with processes involved in tumour biology, and that overlap is exactly why an oncologist's input matters rather than an internet consensus.

Pregnant and nursing dogs are a second category. There is no adequate canine safety data to draw on, and pawgen's own guidance on these compounds resolves to the veterinarian rather than to a protocol.

Puppies with open growth plates, dogs on immunosuppressive protocols, and dogs with significant liver or kidney disease all belong in the same bucket: individualised veterinary judgement, based on that dog's records.

Surgery timing deserves its own mention. Many surgeons ask that supplements be paused for a defined window before anaesthesia so that the peri-operative picture is clean. If your surgical team gives you that instruction, follow it exactly — their instruction outranks anything you read here.

And on dosing: this article contains no numbers, deliberately. Amounts, timing and whether a peptide stack is appropriate at all are decisions to make with your veterinarian, who can weigh your dog's weight, bloodwork, diagnosis and current medications together.

Multi-ingredient chews are where interaction questions get genuinely messy

Here is the irony of the interaction worry. The hardest products to assess are rarely the single-purpose ones — they are the kitchen-sink joint chews stacked with a dozen botanicals under a proprietary blend heading.

Proprietary blend labelling means the manufacturer discloses the ingredients but not the amounts. Several botanicals common in those chews have real pharmacological activity: willow bark contains salicylates, curcumin and boswellia are studied for anti-inflammatory effects, and high-dose fish oil has documented effects on platelet function. Ask your vet whether a chew interacts with your dog's NSAID and the honest answer is often that they cannot tell you, because the label does not say how much of anything is in there.

That is where transparency stops being a marketing word and becomes a clinical tool. A formulation with a short, disclosed ingredient list and a third-party certificate of analysis is a document a veterinarian can actually read and reason about. K9-REPAIR is built that way: BPC-157 and TB-500, nothing hidden behind a blend name, dosed by body weight, third-party tested with COAs available, and shipped direct to the door with a 60-day money-back guarantee. It is the stack owners are adopting through recovery precisely because they can hand the details to their vet without guessing.

How to actually have this conversation with your veterinarian

Make it concrete rather than theoretical.

Bring the product itself, or a photo of the full label, plus the certificate of analysis. Vets are used to owners describing a supplement vaguely; a document changes the quality of the answer.

List everything, not just the obvious things. Prescriptions, over-the-counter joint chews, calming treats, fish oil, dental additives, and anything a previous clinic prescribed and never formally stopped. Supplements hidden inside treats are the most commonly forgotten items on that list.

Ask three practical questions: is there anything in my dog's history that makes this a bad idea; what should I watch for; and does anything need to pause before the next procedure or injection.

Then monitor and report. New irritability when your dog is handled, a drop in appetite, vomiting, diarrhoea, lethargy or any change at an injection site are all worth a phone call. Those observations are also how your vet distinguishes a supplement question from a genuine change in the underlying orthopaedic problem.

Key Takeaways

• The Wolverine Stack is the informal name for BPC-157 and TB-500 used together; neither is an FDA-approved veterinary drug, and no canine interaction database exists for them.
• Peptides are cleared by peptidase enzymes rather than the hepatic pathways behind most classic drug-drug interactions, which is the mechanistic reason owners run them alongside prescribed care.
• Shared clearance is not the only route to an interaction — overlapping effects on inflammation, clotting and vessel biology are worth a veterinary opinion.
• Never reduce or stop an NSAID, gabapentin, a prescribed injection or any other medication to accommodate a supplement.
• Cancer history, pregnancy, nursing, puppies, immunosuppression and upcoming anaesthesia all warrant an individual discussion.
• Proprietary-blend chews are harder to assess than a transparent, third-party-tested single-purpose formulation with published COAs.
• Dosing questions belong to your veterinarian, always.

The order of operations that keeps a dog safe

Your veterinarian owns the diagnosis and the treatment plan. Imaging, surgical decisions, pain protocols and the rehab timeline are theirs to set, and a recovering dog does best when those decisions are followed precisely. Supplements and peptides operate in the space that proper veterinary care creates — supporting the conditions around a healing joint, never substituting for the plan that made healing possible in the first place.

For related reading on situations that need individual veterinary input, see tb-500 nursing dogs and tb-500 dogs with cancer, or review the full formulation details for K9-REPAIR.

Owners exploring peptide support for their dog can review K9-REPAIR — BPC-157 + TB-500 formulated for dogs — at https://pawgen.com/. BPC-157 and TB-500 are not FDA-approved veterinary drugs. Nothing in this article treats, cures or prevents any condition; every decision about your dog's care belongs with your veterinarian.